 |
|
NYCU Confirms That Hesperetin Allows Doxorubicin to Fight Cancer Without “Harming the Heart”
|
|
Doxorubicin is a chemotherapy drug commonly used to treat cancers such as breast cancer, lymphoma, and leukemia, and the issue of cardiotoxicity it causes has plagued the medical field for over half a century. Statistics show that approximately 5-9% of patients develop significant heart failure or cardiomyopathy following treatment, and the risk of developing chronic heart failure within 10 years ranges from 4-10%.…
|
|